TrialDrug safety2021

Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.

Fumihiko Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.